Fig. 3From: Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment responseVEGF (top), HGF (middle) and angiopoietin-2 (bottom) levels per time point (baseline, +0, +1, +3, +7 and +30 days post treatment, respectively), for patients with liver only disease and (n = 30) versus patients with extrahepatic disease (n = 12)Back to article page